Myosin Therapeutics Inc.
PrivateLast Round
Grant
Mar 19, 2026
Est. Valuation
$28M
Total Funding Raised
$15.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Myosin Therapeutics Inc. operates in Healthcare & Life Sciences and is based in Jupiter, Florida. Its latest recorded funding round was a Grant round in March 2026.
Myosin Therapeutics Inc. is a biotechnology company that develops novel pharmacotherapies targeting members of the myosin family of molecular motors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myosin Therapeutics Inc. Comparables
Compare Myosin Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hemispherian AS | 85% | |
| Gibson Oncology, LLC | 84% | |
| Siren Biotechnology | 81% |
For institutional investors. Book with your work email.
Myosin Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 19, 2026 | ||||
| Grant | Aug 19, 2025 | ||||
| Grant | Apr 28, 2025 | ||||
| Seed | Feb 26, 2025 | ||||
| Seed | Mar 14, 2023 |
For institutional investors. Book with your work email.
Myosin Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Florida Venture Forum | Seed |
| Mint12 Pharma | Seed |
| DeepWork Capital | Seed |
| The Sontag Foundation | Seed |
| Mayo Clinic Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 86% MoM.
- Mar 24, 2026
$2M raised in grant funding.
For institutional investors. Book with your work email.
Myosin Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Myosin Therapeutics Inc.'s valuation, stock price, and market status.
Is Myosin Therapeutics Inc. a public or private company?
Myosin Therapeutics Inc. is a private company.
What is the current stock price of Myosin Therapeutics Inc.?
Myosin Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Myosin Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Myosin Therapeutics Inc. worth (valuation)?
Myosin Therapeutics Inc.'s valuation is estimated at $28.0M based on funding round data.
Can I buy Myosin Therapeutics Inc. stock?
Myosin Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Myosin Therapeutics Inc.'s last funding round?
Myosin Therapeutics Inc.'s most recent funding round was Grant on March 19, 2026.
Who are the main investors in Myosin Therapeutics Inc.?
Key investors in Myosin Therapeutics Inc. include Florida Venture Forum, Mint12 Pharma, DeepWork Capital.
Will Myosin Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Myosin Therapeutics Inc..
How can I track Myosin Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Myosin Therapeutics Inc.'s shares on secondary markets.